Cubist Pharmaceuticals Inc. (CBST)
-NasdaqGS 49.51 
0.88(1.81%) 18 May 04:00 SGT|After Hours
:
48.69 0.82 (1.66%) 18 May 05:39 SGT
| Prev Close: | 48.63 |
|---|
| Open: | 48.71 |
|---|
| Bid: | N/A |
|---|
| Ask: | 54.11 x 100 |
|---|
| 1y Target Est: | 52.00 |
|---|
| Beta: | 0.54 |
|---|
| Next Earnings Date: | 17-Jul-13 |
|---|
| Day's Range: | 48.35 - 49.62 |
|---|
| 52wk Range: | 36.73 - 49.86 |
|---|
| Volume: | 976,865 |
|---|
| Avg Vol (3m): | 765,190 |
|---|
| Market Cap: | 3.23B |
|---|
| P/E (ttm): | 27.57 |
|---|
| EPS (ttm): | 1.80 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- A Disconnect Between Future Prospects of Drug Candidates Versus Where Share Price is Currently Trading: Portfolio Manager Finny Kuruvilla Discusses the Biotech and Pharmaceutical SectorsWall Street Transcript(Fri, 17 May)
- Pipeline Progress at GileadZacks(Fri, 17 May)
- Trius Patent Intrigues Investors, And Perhaps Cubist Pharmaceuticalsat Seeking Alpha(Thu, 16 May)
- Cubist bid for Optimer before sale process began-sourcesat Reuters(Thu, 16 May)
- Cempra/Toyama Ink DealZacks(Thu, 16 May)
- Cubist bid almost $1 billion for Optimer before sale process: sourcesat Reuters(Thu, 16 May)
- Cubist bid almost $1 bln for Optimer before sale process-sourcesat Reuters(Thu, 16 May)
- Cubist antibiotic regimen gets fast-track reviewAP(Wed, 8 May)
- Alnylam takes smaller 1Q loss on lower costsAP(Tue, 7 May)
- Cubist Pharma 1Q income falls after acquisitionAP(Fri, 19 Apr)
Key Statistics
| Forward P/E (1 yr): | 27.81 |
|---|
| P/S (ttm): | 3.36 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 1.23 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.37 |
|---|
| Mean Recommendation*: | 2.3 |
|---|
| PEG Ratio (5 yr expected): | 1.36 |
|---|
Business Summary
Cubist Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of pharmaceutical products for various medical needs in the acute care environment in the United States.
View More